These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 11294081)
21. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology. Korff S; Harvey BH Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714 [TBL] [Abstract][Full Text] [Related]
22. Nicotinic cholinergic antagonists: a novel approach for the treatment of autism. Lippiello PM Med Hypotheses; 2006; 66(5):985-90. PubMed ID: 16406687 [TBL] [Abstract][Full Text] [Related]
23. Neurobiological correlates of autism: a review of recent research. Penn HE Child Neuropsychol; 2006 Feb; 12(1):57-79. PubMed ID: 16484102 [TBL] [Abstract][Full Text] [Related]
24. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. McDougle CJ; Scahill L; McCracken JT; Aman MG; Tierney E; Arnold LE; Freeman BJ; Martin A; McGough JJ; Cronin P; Posey DJ; Riddle MA; Ritz L; Swiezy NB; Vitiello B; Volkmar FR; Votolato NA; Walson P Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):201-24. PubMed ID: 10674197 [TBL] [Abstract][Full Text] [Related]
25. Domains of social communication handicap in autism spectrum disorder. Robertson JM; Tanguay PE; L'Ecuyer S; Sims A; Waltrip C J Am Acad Child Adolesc Psychiatry; 1999 Jun; 38(6):738-45. PubMed ID: 10361793 [TBL] [Abstract][Full Text] [Related]
26. Neurobiological correlates of social functioning in autism. Neuhaus E; Beauchaine TP; Bernier R Clin Psychol Rev; 2010 Aug; 30(6):733-48. PubMed ID: 20570622 [TBL] [Abstract][Full Text] [Related]
27. [Clinical report on pharmacological treatment of autism]. Thivierge J Sante Ment Que; 1998; 23(1):85-95. PubMed ID: 9775955 [TBL] [Abstract][Full Text] [Related]
28. Why is vitamin B6 effective in alleviating the symptoms of autism? Sato K Med Hypotheses; 2018 Jun; 115():103-106. PubMed ID: 29685187 [TBL] [Abstract][Full Text] [Related]
29. [An approach to the pharmacological treatment of autism]. Ruggieri VL Rev Neurol; 1996 Nov; 24(135):1451-5. PubMed ID: 8974754 [TBL] [Abstract][Full Text] [Related]
30. Healthcare for children with autism: the Autism Treatment Network. Coury D; Jones NE; Klatka K; Winklosky B; Perrin JM Curr Opin Pediatr; 2009 Dec; 21(6):828-32. PubMed ID: 19745738 [TBL] [Abstract][Full Text] [Related]
31. Pharmacologic treatment for the core deficits and associated symptoms of autism in children. West L; Waldrop J; Brunssen S J Pediatr Health Care; 2009; 23(2):75-89. PubMed ID: 19232924 [TBL] [Abstract][Full Text] [Related]
32. Safety issues with drug therapies for autism spectrum disorders. McCracken JT J Clin Psychiatry; 2005; 66 Suppl 10():32-7. PubMed ID: 16401148 [TBL] [Abstract][Full Text] [Related]
33. Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. Trottier G; Srivastava L; Walker CD J Psychiatry Neurosci; 1999 Mar; 24(2):103-15. PubMed ID: 10212552 [TBL] [Abstract][Full Text] [Related]
34. Oxytocin and experimental therapeutics in autism spectrum disorders. Bartz JA; Hollander E Prog Brain Res; 2008; 170():451-62. PubMed ID: 18655901 [TBL] [Abstract][Full Text] [Related]
35. Explaining autism: Ten reasons to focus on the developing self. Hobson RP Autism; 2010 Sep; 14(5):391-407. PubMed ID: 20926456 [TBL] [Abstract][Full Text] [Related]
36. An update on pharmacologic treatments for autism spectrum disorders. King BH; Bostic JQ Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):161-75. PubMed ID: 16321729 [TBL] [Abstract][Full Text] [Related]
37. Social-skills treatments for children with autism spectrum disorders: an overview. Matson JL; Matson ML; Rivet TT Behav Modif; 2007 Sep; 31(5):682-707. PubMed ID: 17699124 [TBL] [Abstract][Full Text] [Related]